Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group Inc.?

Home Capital Group Inc. (TSX:HCG) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have seen their stock prices fall this year. Can either company recover?

| More on:

Stocks that have seen prices decline as a result of scandals and problems present buying opportunities for investors that are not risk averse. The danger in investing in a company that is in turmoil is that the stock could continue to plummet with no end in sight. The easiest example is Sears Canada Inc., which is now in the process of liquidation; months ago, it might have been seen as a bargain opportunity if it could turn things around.

But if is a dangerous word, and just because a stock has declined is not a reason to invest. Instead, it is important, once you find these “bargain” stocks, to look at the company’s financials and assess its long-term prospects. If a company is heavy on debt, sales are declining, and there doesn’t look to be light at the end of the tunnel, it’s best to stay away from the free-falling stock. However, a company ridden by scandals or bad press but has good financials and a promising future might present a good long-term opportunity, as long as you can stomach the fluctuations in the process.

I’ll look at two companies’ stocks that have taken a beating and could present strong long-term upside.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen its stock tumble 30% in the past year, and over five years, the stock has declined by over 58%. The company was trading at over $319 a share in September 2015 when news came out about Valeant’s purchase of Addyi, the “female Viagra” pill. The problem with the purchase is, although it was FDA approved, the drug had serious health risks associated with it. Valeant purchased the maker of the high-risk drug for $1 billion, and, as a result, the stock plummeted to $100 a share and soon reached just $34.

Big risks aren’t the only items that have concerned investors. The company is heavily leveraged in debt. At the end of 2015, the company had a debt-to-equity ratio of 5.26 with debt levels reaching over $30 billion. The company was able to bring debt levels down to $29 billion, but a dropping equity resulted in the ratio rising to 9.46 for the end of 2016.

Although the company has expressed a desire to continue paying down its debt, it may be a losing battle, as the company still expects to make large investments into research and development.

Home Capital Group Inc. (TSX:HCG) is a very different case of a company that has been ridden with bad press and scandals in the past several months. The mortgage lender has been involved in fraudulent mortgage applications, and the company’s CEO was fired earlier this year amid accusations of misleading investors.

These types of scandals don’t fade from memory easily, but Berkshire Hathaway Inc. came to the rescue. Berkshire has provided Home Capital with some life support. Home Capital is a bit heavy on debt as well, but with a debt-to-equity ratio of just 1.63 for the latest year, it pales in comparison to the problem Valeant has.

With the problems and individuals associated with fraudulent activities removed from the company, a better balance sheet, and reasonable prospects for a recovery, Home Capital presents a much more attractive opportunity for investors than Valeant.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

RRSP (Registered Retirement Savings Plan) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

RRSP Investors: 2 Discounted TSX Dividend Stocks to Consider Now

These stocks offer attractive dividend yields today.

Read more »

Man looks stunned about something
Dividend Stocks

The Most Expensive TFSA Mistake Investors Are Making Right Now

Waiting for the “perfect” TFSA buying day can quietly cost you tens of thousands in lost compounding.

Read more »

concept of growth
Dividend Stocks

TFSA Income: 2 High-Yield Stocks to Consider Today

These stocks currently offer yields well above 5%.

Read more »

builder frames a house with lumber
Dividend Stocks

Here Are 2 TSX Stocks I’d Buy Before They Bounce Back

Two quality TSX stocks trading at a discount offer good entry points before a strong rebound.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

2 Canadian AI Stocks That Could Turn $5,000 Into $50,000

Two under-the-radar Canadian AI software stocks could turn a small $5,000 stake into something much bigger over time.

Read more »

concept of growth
Stocks for Beginners

How a $20,000 TFSA Could Grow Into $100,000 by 2030

Turning $20,000 into $100,000 by 2030 is possible, but it takes steady TFSA contributions and real growth.

Read more »

runner checks her biodata on smartwatch
Dividend Stocks

Here Are 3 Dividend Stocks I’d Lock In My TFSA for Good

These Canadian stocks are backed by fundamentally strong businesses with a solid history of rewarding shareholders.

Read more »

crisis concept, falling stairs
Tech Stocks

Down 6.8% After Earnings, Is Constellation Software a Good Stock to Buy Now?

Understand the factors influencing Constellation Software's stock movement and its potential for future growth in the market.

Read more »